Combined Cardioverting/defibrillating And Pacing Patents (Class 607/4)
-
Patent number: 10846893Abstract: A system for facilitating identification and marking of a target in a fluoroscopic image of a body region of a patient, the system comprising one or more storage devices having stored thereon instructions for: receiving a CT scan and a fluoroscopic 3D reconstruction of the body region of the patient, wherein the CT scan includes a marking of the target; and generating at least one virtual fluoroscopy image based on the CT scan of the patient, wherein the virtual fluoroscopy image includes the target and the marking of the target, at least one hardware processor configured to execute these instructions, and a display configured to display to a user the virtual fluoroscopy image and the fluoroscopic 3D reconstruction.Type: GrantFiled: May 27, 2020Date of Patent: November 24, 2020Assignee: COVIDIEN LPInventors: Oren P. Weingarten, Ron Barak, Evgeni Kopel, Benjamin Greenburg, Efrat Kedmi-Shahar, Dafna Mardix, Ariel Birenbaum, Guy Alexandroni, Eyal Klein
-
Patent number: 10821288Abstract: Implantable medical devices (IMD) such as a cardiac pacemakers may include a sensor and electrodes. In some cases, the IMD may include electronics to use the sensor to determine the heart rate of a patient's heart. The electronics may use the electrodes to deliver pacing pulses to the heart at a first energy level if the heart rate is below a threshold and pace the heart at an enhanced energy level if the heart rate is above the threshold.Type: GrantFiled: March 28, 2018Date of Patent: November 3, 2020Assignee: CARDIAC PACEMAKERS, INC.Inventors: G. Shantanu Reddy, Brian L. Schmidt
-
Patent number: 10814138Abstract: This disclosure relates to active implantable medical devices. Some such devices include a pulse generator and at least one detection electrode. A processor of the pulse generator is configured to collect via the detection electrode at least two EGM signals, combine the EGM signals into two time components, and combine the components into a single 2D parametric characteristic representing the cardiac cycle. During a tachyarrhythmia episode, the device stores the consecutive values of the cycle-to-cycle variation in the amplitude of one EGM signal, distributes same into a plurality of classes each corresponding to an amplitude interval, and performs a statistical analysis of the totals for each class so as to output, selectively, on the basis of at least one predetermined criterion applied to the distribution of the amplitude variations into the various classes, an indicator of a suspected extracardiac artifact or an indicator of tachyarrhythmia.Type: GrantFiled: January 9, 2017Date of Patent: October 27, 2020Assignee: Sorin CRM SASInventors: Marie-Anne Euzen, Paola Milpied
-
Patent number: 10799710Abstract: An implantable medical device system is configured to sense cardiac events in response to a cardiac electrical signal crossing a cardiac event sensing threshold. A control circuit is configured to determine a drop time interval based on a heart rate and control a sensing circuit to hold the cardiac event sensing threshold at a threshold value during the drop time interval.Type: GrantFiled: October 23, 2017Date of Patent: October 13, 2020Assignee: Medtronic, Inc.Inventors: Jian Cao, Gerald P. Arne, Timothy A. Ebeling, Yanina Grinberg, Michael W. Heinks, Paul R. Solheim, Xusheng Zhang
-
Patent number: 10744260Abstract: Techniques for modeling therapy fields for therapy delivered by medical devices are described. Each therapy field model is based on a set of therapy parameters and represents where therapy will propagate from the therapy system delivering therapy according to the set of therapy parameters. Therapy field models may be useful in guiding the modification of therapy parameters. As one example, a processor compares an algorithmic model of a therapy field to a reference therapy field and adjusts at least one therapy parameter based on the comparison. As another example, a processor adjusts at least one therapy parameter to increase an operating efficiency of the therapy system while substantially maintaining the modeled therapy field.Type: GrantFiled: September 19, 2017Date of Patent: August 18, 2020Assignee: Medtronic, Inc.Inventors: Martin T. Gerber, John C. Rondoni
-
Patent number: 10737090Abstract: An external defibrillator system may include processing circuitry; signal generation circuitry communicatively coupled to the processing circuitry; and a plurality of electrodes, each including an electrode body electrically coupled to the signal generation circuitry and configured to deliver an electrical pulse therapy to a patient; and an electrolyte dispersal pad that includes a substrate defining a plurality of wells, each defining an opening; an electrolyte material, e.g., fluid, disposed within at least a portion of the plurality of wells; and a conductive material disposed over at least a portion of the openings and configured to retain the electrolyte material within the plurality of wells, where the processing circuitry is configured control the signal generation circuitry to pass a current pulse through a portion of the conductive material to fuse the portion of the conductive material to release the electrolyte material from at least one of the wells.Type: GrantFiled: July 11, 2017Date of Patent: August 11, 2020Assignee: Medtronic, Inc.Inventors: Randolph E. Crutchfield, Gerard A. Bast, David A. Cano, Lisa Anne Harness Mesias, Clark B. Norgaard, Mark E. Porter, Jerome Sims, II, Philip Timson
-
Patent number: 10699448Abstract: A system for facilitating identification and marking of a target in a fluoroscopic image of a body region of a patient, the system comprising one or more storage devices having stored thereon instructions for: receiving a CT scan and a fluoroscopic 3D reconstruction of the body region of the patient, wherein the CT scan includes a marking of the target; and generating at least one virtual fluoroscopy image based on the CT scan of the patient, wherein the virtual fluoroscopy image includes the target and the marking of the target, at least one hardware processor configured to execute these instructions, and a display configured to display to a user the virtual fluoroscopy image and the fluoroscopic 3D reconstruction.Type: GrantFiled: June 28, 2018Date of Patent: June 30, 2020Assignee: COVIDIEN LPInventors: Oren P. Weingarten, Ron Barak, Evgeni Kopel, Benjamin Greenburg, Efrat Kedmi-Shahar, Dafna Mardix, Ariel Birenbaum, Guy Alexandroni, Eyal Klein
-
Patent number: 10687716Abstract: A method includes, in a living organ (28) in which an ambient pressure varies as a function of time, sensing the ambient pressure using a pressure sensor (36, 90, 174), which has a capacitance that varies in response to the ambient pressure, so as to produce a time-varying waveform. A calibration voltage, which modifies the capacitance and thus the time-varying waveform, is applied to the pressure sensor. The time-varying waveform is processed so as to isolate and measure a contribution of the calibration voltage to the waveform. A dependence of the capacitance on the ambient pressure is calibrated using the measured contribution of the calibration voltage.Type: GrantFiled: November 10, 2013Date of Patent: June 23, 2020Assignee: VECTORIOUS MEDICAL TECHNOLOGIES LTD.Inventors: Oren Goldshtein, Shmuel Livne
-
Patent number: 10675478Abstract: This disclosure describes an implantable medical electrical lead and an ICD system utilizing the lead. The lead includes a lead body defining a proximal end and a distal portion, wherein at least a part of the distal portion of the lead body defines an undulating configuration. The lead includes a defibrillation electrode that includes a plurality of defibrillation electrode segments disposed along the undulating configuration spaced apart from one another by a distance. The lead also includes at least one electrode disposed between adjacent sections of the plurality of defibrillation sections. The at least one electrode is configured to deliver a pacing pulse to the heart and/or sense cardiac electrical activity of the heart.Type: GrantFiled: December 9, 2015Date of Patent: June 9, 2020Assignee: Medtronic, Inc.Inventors: Mark T. Marshall, Gonzalo Martinez, Vladimir P. Nikolski, Nathan L. Olson, Kevin R. Seifert, Teresa A. Whitman
-
Patent number: 10668296Abstract: A handheld defibrillation device is disclosed, operated by a single battery cell, and configured to deliver a defibrillation pulse to a subject via defibrillation pads. The defibrillator comprises an energy storage unit comprising a plurality of capacitive elements, a plurality of charger units, each charger unit being electrically connected to the battery cell for electrically charging a respective one of the capacitive elements, and a pulse delivery unit configured and arranged to discharge the electrical charges of the capacitive elements through the defibrillation pads. The charging units and the pulse delivery unit, and various other parts of the defibrillator are specially designed to permit compactly packaging the defibrillator inside a handheld pocketsize housing.Type: GrantFiled: November 23, 2016Date of Patent: June 2, 2020Assignee: CARDIFAB LTD.Inventor: Marian Meir
-
Patent number: 10661073Abstract: Implantable medical electrical leads having electrodes arranged such that a defibrillation coil electrode and a pace/sense electrode(s) are concurrently positioned substantially over the ventricle when implanted as described. The leads include an elongated lead body having a distal portion and a proximal end, a connector at the proximal end of the lead body, a defibrillation electrode located along the distal portion of the lead body, wherein the defibrillation electrode includes a first electrode segment and a second electrode segment proximal to the first electrode segment by a distance. The leads may include at least one pace/sense electrode, which in some instances, is located between the first defibrillation electrode segment and the second defibrillation electrode segment.Type: GrantFiled: November 27, 2018Date of Patent: May 26, 2020Assignee: Medtronic, Inc.Inventors: Mark T. Marshall, Jian Cao, Melissa G. T. Christie, Paul J. Degroot, Vladimir P. Nikolski, Amy E. Thompson-Nauman
-
Patent number: 10646131Abstract: An apparatus includes a cardiac signal sensing circuit configured to generate a sensed cardiac signal representative of electrical cardiac activity of a subject, a buffer memory and a pause detection circuit. The pause detection circuit is configured to: identify ventricular depolarization in the cardiac signal or the sampled cardiac signal; detect a candidate pause episode using the cardiac signal in which delay in ventricular depolarization exceeds a specified delay threshold; identify noise events in a stored cardiac signal; and discard the cardiac signal of the candidate pause episode when a number of noise events satisfies a specified noise event number threshold, otherwise store the cardiac signal of the candidate pause episode as a bradycardia pause episode.Type: GrantFiled: September 7, 2017Date of Patent: May 12, 2020Assignee: Cardiac Pacemakers, Inc.Inventors: Krzysztof Z. Siejko, Derek D. Bohn, David L. Perschbacher, Adam MacEwen, Sunipa Saha, Keith L. Herrmann
-
Patent number: 10632320Abstract: A defibrillation system for the administration of a dual sequential defibrillation and/or simultaneous defibrillation therapy. A first defibrillation device is inductively coupled to a second defibrillation device. An energy delivery of the first defibrillation device generating, or causing to be generated, an artifact that is received by the second defibrillation device. The artifact causing a sync mode, or sync mode circuitry, of the second defibrillation device to administer a second energy delivery. The second energy delivery can be delayed relative to the energy delivery by the first defibrillation device.Type: GrantFiled: October 19, 2017Date of Patent: April 28, 2020Assignee: PHYSIO-CONTROL, INC.Inventors: Gary DeBardi, Fred W. Chapman, Tyson G. Taylor, Ronald E. Stickney
-
Patent number: 10617876Abstract: An implantable medical device comprising a housing having an outer surface; and protrusions disposed on the outer surface, where the plurality of protrusions are configured to reduce at least one of rotational, translational, and lateral movement of the implantable medical device within a patient's tissue after implantation in the patient.Type: GrantFiled: April 17, 2017Date of Patent: April 14, 2020Assignee: Cardiac Pacemakers, Inc.Inventors: Jean M. Bobgan, David P. Stieper
-
Patent number: 10602945Abstract: A physiological signal monitoring system includes a single set of sensing electrodes to provide conditioned physiological signals to a primary monitoring device and a secondary monitoring device. The monitoring system includes pre-processing circuitry configured to receive a raw physiological signal. The pre-processing circuitry is configured to produce a primary physiological signal and a secondary physiological signal. Each of the primary and secondary physiological signals are conditioned. The primary conditioned physiological signal is directed to a primary monitoring device such as a hospital wearable defibrillator device. The secondary conditioned physiological signal is directed to telemetry modeling circuitry where it is further processed to output one or more telemetry signals. The one or more telemetry signals are output to a secondary monitoring device such as a three lead ECG monitoring device.Type: GrantFiled: March 13, 2018Date of Patent: March 31, 2020Assignee: ZOLL Medical CorporationInventors: Shane Volpe, Gary A. Freeman
-
Patent number: 10575776Abstract: The invention includes a system and method for predicting the performance of production animals by analysis of heart and lung sounds to determine likelihoods the animals will develop BRD or other diseases or ailments. Vital signs of animals are recorded during an adrenergic sympathetic “flight or fight” situation. A cardio-pulmonary rate ratio is determined for each animal by dividing a normalized adjusted heart rate value by a normalized adjusted respiratory value. From the ratios calculated for each animal in a group, a ratio range is established. Ratio values at a lower end of the ratio range indicate higher relative respiration rates and poor lung performance due to disease. Ratio values at an upper end of the range may indicate low cardiac output and an inability to tolerate rapid weight gain. Ratio values at either end of the range may indicate compromised cardio-pulmonary function.Type: GrantFiled: April 29, 2015Date of Patent: March 3, 2020Assignee: INTERVET INC.Inventor: Kurt Brattain
-
Patent number: 10556118Abstract: An extra-cardiovascular implantable cardioverter defibrillator (ICD) having a low voltage therapy module and a high voltage therapy module is configured to select, by a control module of the ICD, a pacing output configuration from at least a low-voltage pacing output configuration of the low voltage therapy module and a high-voltage pacing output configuration of the high voltage therapy module. The high voltage therapy module includes a high voltage capacitor having a first capacitance and the low voltage therapy module includes a plurality of low voltage capacitors each having up to a second capacitance that is less than the first capacitance. The ICD control module controls a respective one of the low voltage therapy module or the high voltage therapy module to deliver extra-cardiovascular pacing pulses in the selected pacing output configuration via extra-cardiovascular electrodes coupled to the ICD.Type: GrantFiled: September 17, 2018Date of Patent: February 11, 2020Assignee: Medtronic, Inc.Inventors: David A. Anderson, Mark T. Marshall, Vladimir P. Nikolski, Robert T. Sawchuk, Amy E. Thompson-Nauman, John D. Wahlstrand, Gregory A. Younker
-
Patent number: 10548498Abstract: An implantable device for analyzing a high frequency (HF) electrogram signal received from subcutaneous, above-rib pickup locations, the device including an implantable electrode for use inside a living body, and a can for subcutaneous implantation, the can including a signal pickup configured to pick up an electrogram signal including a high frequency (HF) component, a signal filter connected to the signal pickup and configured to measure a high frequency (HF) component from the electrogram signal, and an analyzer for analyzing the HF component of the electrogram signal, wherein the analyzer is configured to analyze at least one time-varying parameter of the HF component of the electrogram signal, and the signal filter is configured to measure the electrogram signal by using a signal picked up from at least two pickup locations which are both subcutaneous and above-rib. Related apparatus and methods are also described.Type: GrantFiled: December 31, 2015Date of Patent: February 4, 2020Assignee: BSP Biological Signal Processing Ltd.Inventors: Tamir Ben-David, Yair Granot, Amir Beker
-
Patent number: 10543375Abstract: A wearable medical system includes a support structure with one or more electrodes in an unbiased state. A monitoring device monitors, for the long term, a blood-related parameter of the person. When a value of the monitored parameter reaches a threshold, such as when the person is having an actionable episode, the one or more electrodes become mechanically biased against the person's body, for making good electrical contact. As such, the one or more electrodes of the wearable medical system can be worn loosely for the long term, without making good electrical contact. This can reduce the person's aversion to wearing the medical system.Type: GrantFiled: June 19, 2018Date of Patent: January 28, 2020Assignee: WEST AFFUM HOLDINGS CORP.Inventors: Fred W. Chapman, Gregory T. Kavounas
-
Patent number: 10542939Abstract: Embodiments of the present disclosure describe a method of monitoring a patient comprising generating an accelerometer signal of a patient via a patient medical device and capturing and sampling the accelerometer signal at a sampling rate that utilizes non-regular timing intervals. Embodiments further describe a patient medical device comprising sensors for monitoring an accelerometer signal of a patient and circuitry for sampling the accelerometer signal at a sampling rate that utilizes non-regular timing intervals. Embodiments also describe a method of processing physiological signals comprising monitoring ECG signals and accelerometer signals of a patient via a patient medical device and capturing an ECG segment and sampling the accelerometer signal at a sampling rate that utilizes non-regular timing intervals.Type: GrantFiled: November 14, 2016Date of Patent: January 28, 2020Assignee: Medtronic Monitoring, Inc.Inventors: Rodolphe Katra, Matthew Edelman, Scott Williams, Niranjan Chakravarthy, Arthur Lai
-
Patent number: 10478128Abstract: There is provided a system architecture including a PPG hardware module and a MEMS hardware module. The PPG hardware module processes PPG raw data, which is generally composed of analog signals or digital signals. The PPG hardware module filters the raw data for later digital calculation to, for example, find out frequency signals with higher peak values. The PPG hardware module then outputs the selected frequency signals to an MCU for heart rate calculation. The MEMS hardware module receives MEMS raw data from a motion detector made of MEMS elements. The MEMS raw data represents motion status of a user that could possibly affect the heart rate determination result. The MEMS hardware module filters the raw data for later digital calculation to find out frequency signals with higher peak values caused by motion.Type: GrantFiled: November 21, 2017Date of Patent: November 19, 2019Assignee: PIXART IMAGING INC.Inventors: Ren-Hau Gu, Yen-Min Chang, Ming-Chang Li, Chih-Hsin Lin
-
Patent number: 10470681Abstract: A medical device, such as an extra-cardiovascular implantable cardioverter defibrillator (ICD), senses R-waves from a first cardiac electrical signal by a first sensing channel and stores a time segment of a second cardiac electrical signal acquired by a second sensing channel in response to each sensed R-wave. The medical device determines at least one noise parameter from a group of the stored time segments of the second cardiac electrical signal, detects noise based on the noise parameter, and withholds detection of a tachyarrhythmia episode in response to detecting the noise.Type: GrantFiled: May 26, 2017Date of Patent: November 12, 2019Assignee: Medtronic, Inc.Inventors: Saul E. Greenhut, Jian Cao, Xusheng Zhang
-
Patent number: 10449361Abstract: Systems and methods for coordinating treatment of abnormal heart activity using multiple implanted devices within a patient. In one example, abnormal heart activity may be sensed by a medical device system. One of the devices of the system may determine to deliver anti-tachycardia pacing therapy to the heart of the patient, and may communicate an instruction to another of the devices of the medical device system to deliver anti-tachycardia pacing (ATP) therapy to the heart. The receiving medical device may then deliver ATP therapy to the heart of the patient.Type: GrantFiled: January 8, 2015Date of Patent: October 22, 2019Assignee: Cardiac Pacemakers, Inc.Inventors: Jeffrey E. Stahmann, Howard D. Simms, Jr., Keith R. Maile, Michael J. Kane, William J. Linder
-
Patent number: 10441796Abstract: The control module of a first pacemaker included in an implantable medical device system including the first pacemaker and a second pacemaker is configured to set a pacing escape interval in response to a far field pacing pulse sensed by the first pacemaker. The far field pacing pulse is a pacing pulse delivered by the second pacemaker. The pacing escape interval is allowed to continue without restarting the in response to a far field intrinsic event sensed by the first pacemaker during the pacing escape interval. The first pacemaker delivers a cardiac pacing pulse to the heart upon expiration of the pacing escape interval.Type: GrantFiled: March 11, 2015Date of Patent: October 15, 2019Assignee: Medtronic, Inc.Inventors: Wade M Demmer, Todd J Sheldon, Saul E Greenhut, James D Reinke
-
Patent number: 10391316Abstract: A medical device system and associated method predict a patient response to a cardiac therapy. The system includes for delivering cardiac pacing pulses to a patient's heart coupled to a cardiac sensing module and a cardiac pacing module for generating cardiac pacing pulses and controlling delivery of the pacing pulses at multiple pace parameter settings. An acoustical sensor obtains heart sound signals. A processor is enabled to receive the heart sound signals, derive a plurality of heart sound signal parameters from the heart sound signals, and determine a trend of each of the plurality of heart sound signal parameters with respect to the plurality of pace parameter settings. An external display is configured to present the trend of at least one heart sound parameter with respect to the plurality of pace parameter settings.Type: GrantFiled: May 8, 2017Date of Patent: August 27, 2019Assignee: Medtronic, Inc.Inventors: Xusheng Zhang, Jeffrey M Gillberg, Thomas J Mullen
-
Patent number: 10369372Abstract: A medical device is configured to deliver an electrical stimulation pulse to a heart of a patient, determine a pre-stimulation cardiac event amplitude prior to delivering the electrical stimulation pulse and adjust a cardiac event sensing threshold according to a first post-stimulation decay sequence in response to the electrical stimulation pulse delivery. The first post-stimulation decay sequence is controlled by a sensing module of the medical device according to a first set of sensing control parameters including at least one sensing control parameter based on the pre-stimulation cardiac event amplitude.Type: GrantFiled: October 21, 2014Date of Patent: August 6, 2019Assignee: Medtronic, Inc.Inventors: Robert W. Stadler, Jian Cao
-
Patent number: 10342980Abstract: The present invention relates to an electrode (30,30?) for implantation in contact with a neural tissue, said electrode extending along an axis, said neural tissue being capable of generating one or more action potentials, and said one or more action potentials propagating with a given speed in said neural tissue. The electrode comprises a carrier (31, 31?) of biocompatible electrically insulating material; stimulation electrode contacts (32a; 32?a; 32b; 32?b) deposited on a surface of said carrier (31, 31?) for applying an electrical stimulation to said neural tissue so as to generate, after a given latency time, a compound action potential when stimulated by said electrical stimulation; one or more sensing electrode contacts (33a; 33b; 33c; 33?a; 33?b; 33?c) deposited on said surface of said carrier and provided at a distance from said stimulation electrode contacts, said sensing electrode contacts being adapted to be connected to measuring means (23) having a given inactive period.Type: GrantFiled: February 1, 2016Date of Patent: July 9, 2019Assignee: Sorin CRM SASInventors: Michel Troosters, Jean Delbeke, Pascal Doguet, Hervé Mével
-
Patent number: 10307324Abstract: We disclose methods and medical device systems for selectively recruiting a nerve fiber type within a cranial nerve, a peripheral nerve or a spinal root. Such a method may comprise applying a first pressure, a heating, and/or a cooling to a second location of the nerve, the pressure, heating, or cooling sufficient to substantially block at least one of activation or conduction in at least one fiber population through the second location of the nerve for a blocking time period; and applying an electrical signal to a first location during the blocking time period.Type: GrantFiled: February 10, 2017Date of Patent: June 4, 2019Inventor: Ivan Osorio
-
Patent number: 10285614Abstract: An implantable cardiac system that includes an implantable cardiac pacemaker or leadless pacemaker (iLP) and a second device such as a subcutaneous implantable cardioverter-defibrillator (S-ICD). The pacemaker includes an R-spike amplifier that amplifies stimulated ventricle excitations or R-waves to increase R-wave to T-wave signal to noise ratio and to improve indirect detection of ventricular rhythm classification by the S-ICD. The S-ICD includes an electrode line for defibrillation, a sensing unit and a stimulation detection unit. The S-ICD records a subcutaneous electrocardiogram between shock electrode poles and provides potentially life-saving therapy based thereon. The system significantly increases the specificity and sensitivity of an S-ICD in combination with an implanted cardiac pacemaker or iLP having an R-spike amplifier.Type: GrantFiled: July 6, 2017Date of Patent: May 14, 2019Assignee: BIOTRONIK SE & Co. KGInventors: Thomas Doerr, Dirk Muessig
-
Patent number: 10278601Abstract: A method and medical device for determining sensing vectors that includes sensing cardiac signals from a plurality of electrodes, the plurality of electrodes forming a plurality of sensing vectors, determining signal differences during a detection window in each of the plurality of sensing vectors, ranking sensing vectors of the plurality of sensing vectors in response to the determined signal differences, and selecting one or more sensing vectors of the plurality of sensing vectors in response to the determined rankings.Type: GrantFiled: April 24, 2014Date of Patent: May 7, 2019Assignee: Medtronic, Inc.Inventors: Saul E Greenhut, Robert W Stadler, Xusheng Zhang
-
Patent number: 10278603Abstract: A system and method for secure physiological data acquisition and storage. An identifier of a physiological monitoring patch is obtained by a programming wand, the patch configured to store the identifier within a cryptographic circuit. A password for accessing physiological monitoring data collected using that patch is generated based on at least a portion of the identifier, the password is encrypted using a secret key, and the encrypted password is loaded into the cryptographic circuit. The key is loaded onto a monitor recorder that couples with the patch and obtains the physiological monitoring data using the patch, wherein the monitor recorder offloads the data together with the identifier and the decoded password. The identifier and the password are reported to a server that stores the offloaded physiological monitoring data using the identifier within a secure database and grants access to the data upon receipt of the decoded password.Type: GrantFiled: April 30, 2018Date of Patent: May 7, 2019Assignee: Bardy Diagnostics, Inc.Inventors: Jason Felix, Ezra M. Dreisbach, Jon Mikalson Bishay, Corey Bailey Williamson, Gust H. Bardy
-
Patent number: 10265534Abstract: Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.Type: GrantFiled: October 26, 2016Date of Patent: April 23, 2019Assignee: Medtronic, Inc.Inventors: Saul E. Greenhut, Robert J. Nehls, Walter H. Olson, Xusheng Zhang, Wade M. Demmer, Troy E. Jackson, James D. Reinke
-
Patent number: 10238882Abstract: Systems and methods for treating cardiac arrhythmias are disclosed. In one embodiment, an SICD comprises two or more electrodes, a charge storage device, and a controller operatively coupled to two or more of the electrodes and the charge storage device. In some embodiments, the controller is configured to monitor cardiac activity of the heart of the patient, detect an occurrence of a cardiac arrhythmia based on the cardiac activity, and determine a type of the detected cardiac arrhythmia from two or more types of cardiac arrhythmias. If the determined type of cardiac arrhythmia is one of a first set of cardiac arrhythmia types, the controller sends an instruction for reception by an LCP to initiate the application of ATP therapy by the LCP. If the determined type of cardiac arrhythmia is not one of the first set cardiac arrhythmia types, the controller does not send the instruction.Type: GrantFiled: May 4, 2017Date of Patent: March 26, 2019Assignee: CARDIAC PACEMAKERSInventor: Brendan E. Koop
-
Patent number: 10220213Abstract: Systems and methods for treating arrhythmias are disclosed. In one embodiment an LCP comprises a housing, a plurality of electrodes for sensing electrical signals emanating from outside of the housing, an energy storage module disposed within the housing, and a control module disposed within the housing and operatively coupled to the plurality of electrodes. The control module may be configured to receive electrical signals via two or more of the plurality of electrodes and determine if the received electrical signals are indicative of a command for the LCP to deliver ATP therapy. If the received electrical signals are indicative of a command for the LCP to deliver ATP therapy, the control module may additionally determine whether a triggered ATP therapy mode of the LCP is enabled. If the triggered ATP therapy mode is enabled, the control module may cause the LCP to deliver ATP therapy via the plurality of electrodes.Type: GrantFiled: February 4, 2016Date of Patent: March 5, 2019Assignee: Cardiac Pacemakers, Inc.Inventors: Paul Huelskamp, Jacob M. Ludwig, Lance E. Juffer, Keith R. Maile
-
Patent number: 10213606Abstract: The present disclosure pertains to cardiac pacing methods and systems, and, more particularly, to cardiac resynchronization therapy (CRT). In particular, the present disclosure pertains to determining whether a patient is experiencing atrial fibrillation (AF). If the patient is experiencing AF, the efficacy of CRT is determined. A signal is sensed in response to a ventricular pacing stimulus. Through signal processing, a number of features are parsed from the signal and a determination is made as to whether the ventricular pacing stimulus evoked a response from the ventricle.Type: GrantFiled: March 14, 2014Date of Patent: February 26, 2019Assignee: Medtronic, Inc.Inventors: Richard M. T. Lu, Subham Ghosh, Robert W. Stadler
-
Patent number: 10213610Abstract: Methods and devices for testing and configuring implantable medical device systems. A first medical device and a second medical device communicate with one another using test signals configured to provide data related to the quality of the communication signal to facilitate optimization of the communication approach. Some methods may be performed during surgery to implant one of the medical devices to ensure adequate communication availability.Type: GrantFiled: March 15, 2016Date of Patent: February 26, 2019Assignee: CARDIAC PACEMAKERS, INC.Inventors: Keith R. Maile, Brendan E. Koop, Brian L. Schmidt, Michael J. Kane, Jacob M. Ludwig, Jeffrey E. Stahmann, Lance E. Juffer
-
Patent number: 10212032Abstract: A method for integrating a medical device into a medical facility network by equipping the medical device with wireless communication device is disclosed. The medical device is provided into a medical treatment area within wireless range of the medical facility network. The medical facility network is configured to detect the medical device upon entry into the medical treatment area, and then recognize or authenticate the medical device. The medical facility network is configured to thereafter transmit an initialization signal to the medical device. A system for integrating medical devices, a medical device capable of integration, and a medical facility network are also disclosed.Type: GrantFiled: January 20, 2017Date of Patent: February 19, 2019Assignee: CAREFUSION 303, INC.Inventor: Robert Andrew Sobie
-
Patent number: 10195421Abstract: A method and system for employing a medical device is disclosed. The medical device includes a housing, a processor disposed within the housing, a connector module, and a medical electrical epicardial lead connected to the processor through the connector module. The epicardial lead is used to sense a cardiac signal from tissue of a patient. The lead comprises an insulative lead body that includes a proximal end and a distal end, at least one conductor disposed in the lead body, and a side helical fixation member, disposed a distance from the distal end, the side helical fixation member. The side helical fixation member comprises a set of windings configured to wrap around the lead body circumference. The side helical fixation member includes a distal tip comprising a sharpened elongated flat free end that is perpendicular to the lead body and angled toward an inside of the set of windings.Type: GrantFiled: August 11, 2016Date of Patent: February 5, 2019Assignee: Medtronic, Inc.Inventors: Mark T. Marshall, Andrea J. Asleson, Jean Rutten
-
Patent number: 10166397Abstract: The present disclosure provides systems and methods for applying intermittent multipoint pacing. An implantable cardiac device includes a plurality of electrodes, and a controller communicatively coupled to the plurality of electrodes and configured to cause the plurality of electrodes to alternate between applying multipoint pacing (MPP) and standard biventricular pacing (BiV) to a patient's heart.Type: GrantFiled: December 2, 2016Date of Patent: January 1, 2019Assignee: Pacesetter, Inc.Inventors: Taraneh Ghaffari Farazi, Mark Carlson
-
Patent number: 10137295Abstract: Implantable medical electrical leads having electrodes arranged such that a defibrillation coil electrode and a pace/sense electrode(s) are concurrently positioned substantially over the ventricle when implanted as described. The leads include an elongated lead body having a distal portion and a proximal end, a connector at the proximal end of the lead body, a defibrillation electrode located along the distal portion of the lead body, wherein the defibrillation electrode includes a first electrode segment and a second electrode segment proximal to the first electrode segment by a distance. The leads may include at least one pace/sense electrode, which in some instances, is located between the first defibrillation electrode segment and the second defibrillation electrode segment.Type: GrantFiled: January 2, 2018Date of Patent: November 27, 2018Assignee: Medtronic, Inc.Inventors: Mark T. Marshall, Jian Cao, Melissa G. T. Christie, Paul J. DeGroot, Vladimir P. Nikolski, Amy E. Thompson-Nauman
-
Patent number: 10080905Abstract: An extra-cardiovascular implantable cardioverter defibrillator (ICD) having a low voltage therapy module and a high voltage therapy module is configured to select, by a control module of the ICD, a pacing output configuration from at least a low-voltage pacing output configuration of the low voltage therapy module and a high-voltage pacing output configuration of the high voltage therapy module. The high voltage therapy module includes a high voltage capacitor having a first capacitance and the low voltage therapy module includes a plurality of low voltage capacitors each having up to a second capacitance that is less than the first capacitance. The ICD control module controls a respective one of the low voltage therapy module or the high voltage therapy module to deliver extra-cardiovascular pacing pulses in the selected pacing output configuration via extra-cardiovascular electrodes coupled to the ICD.Type: GrantFiled: December 2, 2016Date of Patent: September 25, 2018Assignee: Medtronic, Inc.Inventors: David A. Anderson, Mark T. Marshall, Vladimir P. Nikolski, Robert T. Sawchuk, Amy E. Thompson-Nauman, John D. Wahlstrand, Gregory A. Younker
-
Patent number: 10065043Abstract: The present disclosure pertains to cardiac pacing methods and systems, and, more particularly, to cardiac resynchronization therapy (CRT). In particular, the present disclosure pertains to determining whether a patient is experiencing atrial fibrillation (AF). If the patient is experiencing AF, the efficacy of CRT is determined. A signal is sensed in response to a ventricular pacing stimulus. Through signal processing, a number of features are parsed from the signal and a determination is made as to whether the ventricular pacing stimulus evoked a response from the ventricle.Type: GrantFiled: June 9, 2017Date of Patent: September 4, 2018Assignee: Medtronic, Inc.Inventors: Richard M. T. Lu, Subham Ghosh, Robert W. Stadler
-
Patent number: 10052493Abstract: Receiver-stimulator with folded or rolled up assembly of piezoelectric components, causing the receiver-stimulator to operate with a high degree of isotropy are disclosed. The receiver-stimulator comprises piezoelectric components, rectifier circuitry, and at least two stimulation electrodes. Isotropy allows the receiver-stimulator to be implanted with less concern regarding the orientation relative the transmitted acoustic field from an acoustic energy source.Type: GrantFiled: April 25, 2016Date of Patent: August 21, 2018Assignee: EBR Systems, Inc.Inventors: David F. Moore, Paul Mohr, N. Parker Willis, Axel F. Brisken
-
Patent number: 10050476Abstract: Rechargeable implantable cardioverter defibrillator including a hermetically sealed can and at least one lead, coupled with the hermetically sealed can, the hermetically sealed can including at least one high voltage capacitor, an electronic circuit, coupled with the high voltage capacitor and a rechargeable battery, coupled with the electronic circuit and the high voltage capacitor, an outer surface of the hermetically sealed can including an active section and a non-active section, the non-active section being electrically insulated from the active section, wherein a surface area of the active section acts as at least one of an electrode with the lead for forming an electric shock vector for applying a high voltage shock and a sensor for sensing electrical activity and wherein a surface area of the non-active section acts as at least one antenna for transmitting and receiving information wirelessly while also receiving electromagnetic energy to inductively charge the rechargeable battery.Type: GrantFiled: May 11, 2016Date of Patent: August 14, 2018Assignee: NewPace Ltd.Inventors: Gera Strommer, Avraham Broder
-
Patent number: 10028672Abstract: A wearable device which diagnoses personal cardiac health condition by monitoring and analyzing heartbeat includes a motion sensor detecting whether the user is in a motion state; a heart rhythm sensor detecting the user's signal of heartbeat interval; a memory storing algorithm program and database for data process, comparison, and analysis; a microprocessor calculating, filtering and judging the signal of heartbeat interval; and a feedback module displaying or alarming a judgment result, wherein the wearable device continuously detects the user's motion state and heartbeat condition, and detects heart rhythm when the user is not in the motion state to further judge the user's cardiac health condition, such as atrial fibrillation.Type: GrantFiled: February 4, 2016Date of Patent: July 24, 2018Assignees: ACME Portable Corp., ACME Portable Machines, Inc.Inventors: Ching Huang, Changyu Liu, Tsair Kao
-
Patent number: 10016614Abstract: In embodiments, a WCD system includes one or more transducers that may sense patient parameters from different parts of the patient's body, and thus render physiological inputs from those parameters. First aspects and second aspects may be detected from the physiological inputs. An aggregated first aspect may be generated from the detected first aspects, and an aggregated second aspect may be generated from the detected second aspects. An aggregate analysis score may be determined from the aggregated first aspect and the aggregated second aspect. A shock/no shock determination may be made depending on whether or not the aggregate analysis score meets an aggregate shock criterion. Accordingly, such a WCD system can make shock/no shock determinations by aggregating aspects of multiple patient parameters. Accordingly, multiple inputs are considered in making the shock/no shock determination.Type: GrantFiled: January 31, 2017Date of Patent: July 10, 2018Assignee: WEST AFFUM HOLDINGS CORP.Inventor: Joseph L. Sullivan
-
Patent number: 9993653Abstract: In a subcutaneous implantable cardioverter/defibrillator, cardiac arrhythmias are detected to determine necessary therapeutic action. Cardiac signal information is sensed from far field electrodes implanted in a patient. The sensed cardiac signal information is then amplified and filtered. Parameters such as rate, QRS pulse width, cardiac QRS slew rate, amplitude and stability measures of these parameters from the filtered cardiac signal information are measured, processed and integrated to determine if the cardioverter/defibrillator needs to initiate therapeutic action.Type: GrantFiled: November 14, 2016Date of Patent: June 12, 2018Assignee: CAMERON HEALTH, INC.Inventors: Gust H. Bardy, William J. Rissmann, Alan H. Ostroff, Paul J. Erlinger, Venugopal Allavatam
-
Patent number: 9977721Abstract: The present invention provides methods, systems, apparatus, and computer software/program code products adapted for operating in, or in conjunction with, an otherwise conventional computing system, and which enable evaluating, monitoring and predicting the performance of computer systems and individual elements or groups of elements within such computer systems.Type: GrantFiled: July 24, 2014Date of Patent: May 22, 2018Assignee: NETAPP, INC.Inventors: George Smirnov, Leon Fairbanks, Kenneth Hu, David Kaeli
-
Patent number: 9974967Abstract: An implantable electromedical device, including a casing part accommodating an electronic or electric functional unit, an electrode disposed on the outside of the casing part or a line connection, and a feedthrough, which surrounds an orifice of the casing part and accommodates at least one metallic conductor element connecting the electrode or the line connection to the functional unit, and which has a metallic circumferential flange, wherein the feedthrough comprises a ceramic base body, around which the circumferential flange and in which the conductor element are directly shrunk in a positively and non-positively connecting manner.Type: GrantFiled: March 7, 2016Date of Patent: May 22, 2018Assignee: BIOTRONIK SE & Co. KGInventors: Norbert Pscherer, Hermann Kalb, Erich Haas, Sahika Seidler
-
Patent number: 9950178Abstract: The presence of a cardiac pulse in a patient is determined by evaluating fluctuations in an electrical signal that represents a measurement of the patient's transthoracic impedance. Impedance signal data obtained from the patient is analyzed for a feature indicative of the presence of a cardiac pulse. Whether a cardiac pulse is present in the patient is determined based on the feature in the impedance signal data. Electrocardiogram (ECG) data may also be obtained in time coordination with the impedance signal data. Various applications for the pulse detection of the invention include detection of PEA and prompting PEA-specific therapy, prompting defibrillation therapy and/or CPR, and prompting rescue breathing depending on detection of respiration.Type: GrantFiled: January 15, 2010Date of Patent: April 24, 2018Assignee: Physio-Control, Inc.Inventors: Ronald E. Stickney, James W. Taylor, Patricia O'Hearn, Cynthia P. Jayne, Paula Lank, David R. Hampton